WuXi, Biologics

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

WuXi Biologics China

en | CA7609751028 | WUXI | boerse | 67950578 |